CNTA CENTESSA PHARMACEUTICALS PLC US FDA Inspections 8-K Filing 2024 - FDA Clears IND for Phase 1 Clinical Trial of ORX750 for Narcolepsy Treatment Centessa Pharmaceuticals announced that the FDA has cleared the IND to initiate a Phase 1 clinical trial of ORX750 for narcolepsy treatment.Get access to all SEC 8-K filings of the CENTESSA PHARMACEUTICALS PLC